UBS Group
SHAC

UBS Group’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

UBS Group’s Portfolio SHAC Stock Details SHAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-700
Closed -$7K – 11130
2021
Q3 		$7K Sell
700
-269
-28% -$2.6K ﹤0.01% 8371
2021
Q2 		$9K Sell
969
-831
-46% -$8.08K ﹤0.01% 8181
2021
Q1 		$17K Buy
+1,800
New +$17.4K ﹤0.01% 7541

Other funds holding SHAC

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UBS Group's SHAC Position: Q4 2021 in Review

UBS Group sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2021, closing a stake of 700 shares — an estimated $7K sold.

UBS Group first reported a position in SHAC in Q1 2021 and held it in 3 quarters. The position peaked at $17K in Q1 2021. 68 funds tracked by Wall St. Rank hold SHAC as of Q4 2021.

  • UBS Group reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 700 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2021, an estimated $7K.
  • UBS Group first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 3 quarters.
  • UBS Group's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $17K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.